C
Cormorant Asset Management
Boston, Massachusetts
Overview
Cormorant Asset Management is a life sciences and healthcare focused investment firm that primarily invests in public and private biotechnology companies.
Year Founded
2013
AUM
$4.02B
Portfolio Companies
106
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Quince Therapeutics | Jun 2026 | Private Placement | Co-investor |
| Climb Bio, Inc. | May 2026 | Private Placement | Co-investor |
| Terremoto Biosciences | Apr 2026 | Series C | Co-investor |
| Candid Therapeutics, Inc. | Mar 2026 | PIPE | Co-investor |
| Faeth Therapeutics, Inc. | Feb 2026 | M&A | Co-investor |
Key People
Sarah Roxe
Director Of Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
